We are live on !
Find out more
Dmitry Balyasny Balyasny Asset Management
AUM
$80.2B
Turnover
42.78%
1-Year Est. Return
51.53%
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
This Fund
S&P 500
This Quarter Est. Return
+19.41%
1 Year Est. Return
+51.53%
3 Year Est. Return
+149.76%
5 Year Est. Return
+199.38%
10 Year Est. Return
+875.18%
AUM
$80.2B
AUM Growth
+$3.12B
(+4%)
Cap. Flow
-$3.01B
Cap. Flow % of AUM
Cap. Flow %
-3.76%
Top 10 Holdings %
Top 10 Hldgs %
13.57%
Holding
3,665
New
834
Increased
989
Reduced
995
Closed
734
Avg Time Held
Equity + Options
1.1
years
Top 10 Avg Time Held
Equity + Options
0.8
years
Top 20 Avg Time Held
Equity + Options
0.8
years
Avg Time Held Equity only
0.9
years
Top 10 Avg Time Held Equity only
0.4
years
Top 20 Avg Time Held Equity only
0.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SpaceX
SPCX
|
+$577M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$538M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$517M |
| 4 |
Texas Instruments
TXN
|
+$413M |
| 5 |
Roku
ROKU
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hologic
HOLX
|
+$357M |
| 2 |
Meta Platforms (Facebook)
META
|
+$326M |
| 3 |
Johnson Controls International
JCI
|
+$303M |
| 4 |
Applied Materials
AMAT
|
+$285M |
| 5 |
Coterra Energy
CTRA
|
+$285M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 36.95% |
| 2 | Technology | 12.69% |
| 3 | Industrials | 9.95% |
| 4 | Consumer Discretionary | 8.03% |
| 5 | Healthcare | 7.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
601
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$12.9B
| $23.9M | 0.03% |
+248,082
| New | +$23.8M |
2026 Q2
0 quarters
|
|
602
iShares MSCI Emerging Markets ETF
EEM
$29.3B
| $23.9M | 0.03% |
349,321
+87,970
| +34% | +$5.75M |
2026 Q1
1 quarter
|
|
603
Interactive Brokers
IBKR
$37.4B
| $23.9M | 0.03% |
+274,516
| New | +$22.8M |
2026 Q2
0 quarters
|
|
604
MongoDB
MDB
$31.6B
| $23.9M | 0.03% |
71,083
-82,680
| -54% | -$24.8M |
2024 Q2
8 quarters
|
|
605
Yum! Brands
YUM
$41.1B
| $23.8M | 0.03% |
148,808
-471,329
| -76% | -$73M |
2025 Q3
3 quarters
|
|
606
Permian Resources
PR
$21.5B
| $23.7M | 0.03% |
1,287,306
+934,709
| +265% | +$18.8M |
2023 Q4
10 quarters
|
|
607
CVS Health
CVS
$116B
| $23.7M | 0.03% |
228,956
-962,067
| -81% | -$85.9M |
2021 Q1
21 quarters
|
|
608
Minerva Neurosciences
NERV
$106M
| $23.6M | 0.03% |
4,257,000
-1,600
| -0% | -$8.68K |
2026 Q1
1 quarter
|
|
609
PUT
Delta Air Lines
DAL
$53.2B
| $23.6M | 0.03% |
252,100
+68,100
| +37% | +$5.14M |
2021 Q4
18 quarters
|
|
610
Sutro Biopharma
STRO
$149M
| $23.6M | 0.03% |
711,162
+245,370
| +53% | +$7.65M |
2025 Q4
2 quarters
|
|
611
PUT
Coinbase
COIN
$41.9B
| $23.6M | 0.03% |
161,100
-11,400
| -7% | -$2.06M |
2024 Q2
8 quarters
|
|
612
CALL
Lam Research
LRCX
$316B
| $23.5M | 0.03% |
54,300
+6,000
| +12% | +$1.82M |
2024 Q4
6 quarters
|
|
613
Viridian Therapeutics
VRDN
$2.71B
| $23.5M | 0.03% |
1,279,859
-1,036,098
| -45% | -$16.7M |
2025 Q3
3 quarters
|
|
614
Phillips Edison & Co
PECO
$4.92B
| $23.5M | 0.03% |
563,639
-140,983
| -20% | -$5.63M |
2025 Q2
4 quarters
|
|
615
CALL
IBM
IBM
$236B
| $23.5M | 0.03% |
83,400
+43,500
| +109% | +$11M |
2023 Q3
11 quarters
|
|
|
616
PUT
Applied Materials
AMAT
$328B
| $23.3M | 0.03% |
32,200
-2,000
| -6% | -$923K |
2023 Q4
10 quarters
|
|
617
State Street Communication Services Select Sector SPDR ETF
XLC
$22B
| $23M | 0.03% |
+214,642
| New | +$24.5M |
2026 Q2
0 quarters
|
|
618
General Motors
GM
$68.5B
| $23M | 0.03% |
298,053
-525,558
| -64% | -$41.3M |
2018 Q4
30 quarters
|
|
619
PUT
Goldman Sachs
GS
$268B
| $23M | 0.03% |
22,700
+9,500
| +72% | +$9.26M |
2021 Q4
18 quarters
|
|
620
PUT
Palo Alto Networks
PANW
$326B
| $23M | 0.03% |
67,300
-97,300
| -59% | -$22.3M |
2021 Q4
18 quarters
|
|
621
Meritage Homes
MTH
$4.09B
| $22.9M | 0.03% |
273,317
+9,719
| +4% | +$664K |
2024 Q2
8 quarters
|
|
622
Clean Harbors
CLH
$16.8B
| $22.9M | 0.03% |
76,523
+46,102
| +152% | +$13.6M |
2026 Q1
1 quarter
|
|
623
Factset
FDS
$10.9B
| $22.9M | 0.03% |
+99,341
| New | +$22.8M |
2026 Q2
0 quarters
|
|
624
PUT
Pinduoduo
PDD
$109B
| $22.6M | 0.03% |
295,900
+88,100
| +42% | +$8.14M |
2024 Q4
6 quarters
|
|
625
CALL
Coca-Cola
KO
$397B
| $22.5M | 0.03% |
276,600
+168,600
| +156% | +$13.3M |
2023 Q2
12 quarters
|
|
Similar funds
Dmitry Balyasny's Q2 2026 Portfolio in Review
As of Q2 2026, Dmitry Balyasny held 3,665 positions worth $80.2B, up 4% from $77.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Dmitry Balyasny withdrew a net $3.01B in Q2 2026, closing 734 positions and reducing 995 holdings. Its most notable exit was Hologic, an estimated $357M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 37% of assets, down from 39% a quarter earlier, followed by Technology and Industrials.
Against the trend, Dmitry Balyasny opened a new position in SpaceX worth $581M.
- Dmitry Balyasny's largest Q2 2026 buy was SpaceX: 3,397,642 shares worth $581M.
- Dmitry Balyasny added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $538M increase.
- Dmitry Balyasny's biggest Q2 2026 reduction was Meta Platforms (Facebook), cutting an estimated $326M.
- Dmitry Balyasny fully exited Hologic in Q2 2026, selling an estimated $357M.
- Dmitry Balyasny's ten largest holdings make up 14% of its $80.2B portfolio in Q2 2026.
- Dmitry Balyasny opened 834 new positions and closed 734 in Q2 2026.
- Dmitry Balyasny's portfolio value rose 4% quarter-over-quarter to $80.2B.
Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.